Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes

Circulation

Volumn 100, Issue 6, 1999, Pages 614-620

  Aukrust, Pål ^a,b   Müller, Fredrik ^a   Ueland, Thor ^a   Berget, Trude ^a   Aaser, Elinor ^a   Brunsvig, Anne ^a   Solum, Nils Olav ^a   Forfang, Kolbjørn ^a   Frøland, Stig S ^a   Gullestad, Lars ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Angina; Atherosclerosis; CD40; Immunology; Platelets; T cells

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CD40 ANTIGEN; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC ACID DERIVATIVE; WARFARIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DEGRANULATION; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; THROMBOCYTE ACTIVATION; UNSTABLE ANGINA PECTORIS;

EID: 0344850187     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.6.614     Document Type: Article

References (35)

1. Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S, Noda T, Sugi K, Imaizumi T. Increased soluble form of P-selectin in patients with unstable angina. Circulation. 1995;92:1693-1696.
2. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rbuzzi AG, Ciliberto G, Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
3. Serneri GGN, Prisco D, Martini F, Gori AM, Brunelli T, Poggesi L, Rostagno C, Gensini GF, Abbata R. Acute T-cell activation is detectable in unstable angina. Circulation. 1997;95:1806-1812.
4. Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti F, Specchia G, Notario A. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation. 1993;88:358-363.
5. Ross R. The pathogenesis of atherosclerosis in the 1990s. Nature. 1993; 362:801-809.
6. Entmann ML, Ballantyne CM. Inflammation and acute coronary syndromes. Circulation. 1993;88:800-803.
7. Davies MJ. Reactive oxygen species, metalloproteinases, and plaque stability. Circulation. 1998;97:2382-2383.
8. Saren P, Welgus HG, Kovanene PT. TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol. 1996;157:4159-4165.
9. Hollenbaug D, Grosmaire RS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 1992;11:4313-4321.
10. Grewal IS, Flavell RA. The CD40 ligand. Immunol Res. 1997;16:59-70.
11. Henn V, Slupsky JS, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;351:591-594.
12. Buhlmann JE, Noelle RJ. Therapeutic potential for blockade of the CD40 ligand, gp39. J Clin Immunol. 1996;16:83-89.
13. Mach F, Schönbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implication for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci U S A. 1997;94:1931-1936.
14. Schönbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy J-Y, Fabunmi RP, Libby P. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res. 1997;81:448-454.
15. Mach F, Schönbeck U, Bonnefoy J-Y, Pober JS, Libby P. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation. 1997;96:396-399.
16. Zhou L, Stordeur P, de Lavareille A, Thielemans K, Capel P, Goldman M, Pradier O. CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity. Thromb Haemost. 1998;79: 1025-1028.
17. Braunwald E. Unstable angina: a classification. Circulation. 1993;80: 410-414.
18. Holme PA, Müller F, Solum NO, Brosstad F, Frøland SS, Aukrust P. Enhanced activation of platelets with abnormal release of RANTES in HIV-1 infection. FASEB J. 1998;12:79-90.
19. Aandahl EM, Aukrust P, Skålhegg BS, Müller F, Frøland SS, Hansson V, Taskén K. Protein kinase type I antagonist restores immune responses of T-cells from HIV-infected patients. FASEB J. 1998;12:855-862.
20. Aukrust P, Ueland T, Müller F, Andreassen AK, Nordøy I, Aas H, Kjekshus J, Simonsen S, Frøland SS, Gullestad L. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation. 1998;97:1136-1143.
21. Nelken L, Coughlin S, Gordon D, Wilkox J. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest. 1991;88: 1121-1127.
22. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol. 1995;155: 4917-4925.
23. Fransisco JA, Kiener PA, Moran-Davis P, Ledbetter JA, Siegall CB. Cytokine activation sensitizes human monocytic and endothelial cells to the cytotoxic effects of an anti-CD40 immunotoxin. J Immunol. 1996; 157:1652-1658.
24. Grammer AC, Bergman MC, Miura Y, Fujita K, Davis LS, Lipsky PE. The CD40 ligand expressed by human B cells costimulates B cell responses. J Immunol. 1995;154:4996-5010.
25. Galis ZS, Sukhova GK, Libby P. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J. 1995;9:974-980.
26. Miller DL, Yaron R, Yellin MJ. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression. J Leukoc Biol. 1998;63:373-379.
27. Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:2200-2208.
28. Noelle RJ. CD40 and its ligand in host defense. Immunity. 1996;4: 415-419.
29. Jonasson L, Holm J, Skalli O, Bondjerd G, Hansson GK. Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque. Atherosclerosis. 1986;6:131-138.
30. Lundahl TH, Petersson J, Fagerberg IH, Berg S, Lindahl TH. Impaired platelet function correlates with multi-organ dysfunction. Platelets. 1998; 9:223-225.
31. The PARAGON Investigators. International, randomized, controlled trial of Lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. Circulation. 1998;97:2386-2395.
32. Klaus SJ, Pinchuk LM, Ochs HD, Law C-L, Franslow WC, Armitage RJ, Clark EA. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J Immunol. 1994;152: 5643-5652.
33. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430-436.
34. Jovinge S, Ares MPS, Kallin B, Nilsson J. Human monocytes/macrophages release TNF-α in response to Ox-LDL. Arterioscler Thromb Vasc Biol. 1996;16:1573-1579.
35. Schreck R, Rieber P, Baeuerle PA. Reactive oxygen species intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 1991;10:2247-2258.